European journal of heart failure

Keyphrases

Publications

volume 25, number 2, 2023

Camilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, Bart J van Essen, Marco Metra, Leong L Ng, Stefan D Anker, Kenneth Dickstein, Ify R Mordi, Adel Dihoum, Chim C Lang, Dirk J van Veldhuisen, Carolyn S P Lam, Adriaan A Voors
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. European journal of heart failure 25 (2) (2023)
Ioannis Mastoris, Joseph Campain, Gregory D Lewis
Invasive exercise haemodynamics: an oracle in heart failure with preserved ejection fraction diagnosis and prognostication. European journal of heart failure 25 (2) (2023)
Kieran F Docherty, John J V McMurray, Brian L Claggett, Zi Michael Miao, Kirkwood F Adams, Alexandra Arias-Mendoza, John G F Cleland, Rafael Diaz, Luis E Echeverria Correa, G Michael Felker, Candida Fonseca, Jing Li, Marco Metra, Karen Sliwa-Hahnle, Scott D Solomon, Hans J Vandekerckhove, Dragos Vinereanu, Adriaan A Voors, Stephen B Heitner, Stuart Kupfer, Fady I Malik, Lisa Meng, John R Teerlink
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. European journal of heart failure 25 (2) (2023)
Fernando Dominguez, Eva Cabrera
Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine? European journal of heart failure 25 (2) (2023)
Eleni Michou, Desiree Wussler, Maria Belkin, Cornelia Simmen, Ivo Strebel, Albina Nowak, Nikola Kozhuharov, Samyut Shrestha, Pedro Lopez-Ayala, Zaid Sabti, Constantin Mork, Matthias Diebold, Tiffany Péquignot, Katharina Rentsch, Arnold von Eckardstein, Danielle M Gualandro, Tobias Breidthardt, Christian Mueller
Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure. European journal of heart failure 25 (2) (2023)
Gianluigi Savarese, Joann Lindenfeld, Davide Stolfo, Kirkwood Adams, Tariq Ahmad, Nihar R Desai, Enrico Ammirati, Stephen S Gottlieb, Mitchell A Psotka, Giuseppe M C Rosano, Larry A Allen
Use of patient-reported outcomes in heart failure: from clinical trials to routine practice. European journal of heart failure 25 (2) (2023)
Christophe Leclercq, Haran Burri
His bundle pacing for correcting atrioventricular dyssynchrony in heart failure: HYPE or HOPE? European journal of heart failure 25 (2) (2023)
Robert J H Miller, Derek S Chew, Lei Qin, Nowell M Fine, Jieling Chen, John J V McMurray, Jonathan G Howlett, Phil McEwan
Cost-effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure. European journal of heart failure 25 (2) (2023)
Ioannis Mastoris, Joseph Campain, Gregory D Lewis
Invasive exercise haemodynamics: an oracle in heart failure with preserved ejection fraction diagnosis and prognostication. European journal of heart failure 25 (2) (2023)
Guido Grassi
Heart failure related central sympathetic activation: debunking the 'holy grail'? European journal of heart failure 25 (2) (2023)
Fernando Dominguez, Eva Cabrera
Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine? European journal of heart failure 25 (2) (2023)
Eleni Michou, Desiree Wussler, Maria Belkin, Cornelia Simmen, Ivo Strebel, Albina Nowak, Nikola Kozhuharov, Samyut Shrestha, Pedro Lopez-Ayala, Zaid Sabti, Constantin Mork, Matthias Diebold, Tiffany Péquignot, Katharina Rentsch, Arnold von Eckardstein, Danielle M Gualandro, Tobias Breidthardt, Christian Mueller
Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure. European journal of heart failure 25 (2) (2023)
Guido Grassi
Heart failure related central sympathetic activation: debunking the 'holy grail'? European journal of heart failure 25 (2) (2023)
Kieran F Docherty, John J V McMurray, Brian L Claggett, Zi Michael Miao, Kirkwood F Adams, Alexandra Arias-Mendoza, John G F Cleland, Rafael Diaz, Luis E Echeverria Correa, G Michael Felker, Candida Fonseca, Jing Li, Marco Metra, Karen Sliwa-Hahnle, Scott D Solomon, Hans J Vandekerckhove, Dragos Vinereanu, Adriaan A Voors, Stephen B Heitner, Stuart Kupfer, Fady I Malik, Lisa Meng, John R Teerlink
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. European journal of heart failure 25 (2) (2023)
Alberto Aimo, Antoni Bayes-Genis
Biomarkers of inflammation in heart failure: from risk prediction to possible treatment targets. European journal of heart failure 25 (2) (2023)
Eleni Michou, Desiree Wussler, Maria Belkin, Cornelia Simmen, Ivo Strebel, Albina Nowak, Nikola Kozhuharov, Samyut Shrestha, Pedro Lopez-Ayala, Zaid Sabti, Constantin Mork, Matthias Diebold, Tiffany Péquignot, Katharina Rentsch, Arnold von Eckardstein, Danielle M Gualandro, Tobias Breidthardt, Christian Mueller
Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure. European journal of heart failure 25 (2) (2023)
Kieran F Docherty, John J V McMurray, Brian L Claggett, Zi Michael Miao, Kirkwood F Adams, Alexandra Arias-Mendoza, John G F Cleland, Rafael Diaz, Luis E Echeverria Correa, G Michael Felker, Candida Fonseca, Jing Li, Marco Metra, Karen Sliwa-Hahnle, Scott D Solomon, Hans J Vandekerckhove, Dragos Vinereanu, Adriaan A Voors, Stephen B Heitner, Stuart Kupfer, Fady I Malik, Lisa Meng, John R Teerlink
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. European journal of heart failure 25 (2) (2023)
Fernando Dominguez, Eva Cabrera
Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine? European journal of heart failure 25 (2) (2023)
Hoong Sern Lim, Ivan H W Yim
De novo aortic regurgitation related to left ventricular assist device therapy: the difficult questions in need of new perspectives. European journal of heart failure 25 (2) (2023)
Lajjaben Patel, Neil Keshvani, Ambarish Pandey
Are post-influenza vaccine reactions truly 'adverse'? European journal of heart failure 25 (2) (2023)
Iris E Beldhuis, Adriaan A Voors, Jasper Tromp
Rapid uptitration: what's the evidence? European journal of heart failure 25 (2) (2023)
Eleni Michou, Desiree Wussler, Maria Belkin, Cornelia Simmen, Ivo Strebel, Albina Nowak, Nikola Kozhuharov, Samyut Shrestha, Pedro Lopez-Ayala, Zaid Sabti, Constantin Mork, Matthias Diebold, Tiffany Péquignot, Katharina Rentsch, Arnold von Eckardstein, Danielle M Gualandro, Tobias Breidthardt, Christian Mueller
Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure. European journal of heart failure 25 (2) (2023)
Guido Grassi
Heart failure related central sympathetic activation: debunking the 'holy grail'? European journal of heart failure 25 (2) (2023)
Robert J H Miller, Derek S Chew, Lei Qin, Nowell M Fine, Jieling Chen, John J V McMurray, Jonathan G Howlett, Phil McEwan
Cost-effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure. European journal of heart failure 25 (2) (2023)
Stephan von Haehling, Ryosuke Sato, Javed Butler, Stefan D Anker
Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure. European journal of heart failure 25 (2) (2023)
Camilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, Bart J van Essen, Marco Metra, Leong L Ng, Stefan D Anker, Kenneth Dickstein, Ify R Mordi, Adel Dihoum, Chim C Lang, Dirk J van Veldhuisen, Carolyn S P Lam, Adriaan A Voors
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. European journal of heart failure 25 (2) (2023)
Gianluigi Savarese, Joann Lindenfeld, Davide Stolfo, Kirkwood Adams, Tariq Ahmad, Nihar R Desai, Enrico Ammirati, Stephen S Gottlieb, Mitchell A Psotka, Giuseppe M C Rosano, Larry A Allen
Use of patient-reported outcomes in heart failure: from clinical trials to routine practice. European journal of heart failure 25 (2) (2023)
Christophe Leclercq, Haran Burri
His bundle pacing for correcting atrioventricular dyssynchrony in heart failure: HYPE or HOPE? European journal of heart failure 25 (2) (2023)
Alberto Aimo, Antoni Bayes-Genis
Biomarkers of inflammation in heart failure: from risk prediction to possible treatment targets. European journal of heart failure 25 (2) (2023)
Daniela Tomasoni, Marianna Adamo, Marco Metra
February 2023 at a glance: focus on pathophysiology and treatment. European journal of heart failure 25 (2) (2023)
Camilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, Bart J van Essen, Marco Metra, Leong L Ng, Stefan D Anker, Kenneth Dickstein, Ify R Mordi, Adel Dihoum, Chim C Lang, Dirk J van Veldhuisen, Carolyn S P Lam, Adriaan A Voors
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. European journal of heart failure 25 (2) (2023)
Lajjaben Patel, Neil Keshvani, Ambarish Pandey
Are post-influenza vaccine reactions truly 'adverse'? European journal of heart failure 25 (2) (2023)
Stephan von Haehling, Ryosuke Sato, Javed Butler, Stefan D Anker
Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure. European journal of heart failure 25 (2) (2023)
Kieran F Docherty, John J V McMurray, Brian L Claggett, Zi Michael Miao, Kirkwood F Adams, Alexandra Arias-Mendoza, John G F Cleland, Rafael Diaz, Luis E Echeverria Correa, G Michael Felker, Candida Fonseca, Jing Li, Marco Metra, Karen Sliwa-Hahnle, Scott D Solomon, Hans J Vandekerckhove, Dragos Vinereanu, Adriaan A Voors, Stephen B Heitner, Stuart Kupfer, Fady I Malik, Lisa Meng, John R Teerlink
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. European journal of heart failure 25 (2) (2023)
Hoong Sern Lim, Ivan H W Yim
De novo aortic regurgitation related to left ventricular assist device therapy: the difficult questions in need of new perspectives. European journal of heart failure 25 (2) (2023)
Lajjaben Patel, Neil Keshvani, Ambarish Pandey
Are post-influenza vaccine reactions truly 'adverse'? European journal of heart failure 25 (2) (2023)
Ioannis Mastoris, Joseph Campain, Gregory D Lewis
Invasive exercise haemodynamics: an oracle in heart failure with preserved ejection fraction diagnosis and prognostication. European journal of heart failure 25 (2) (2023)
Stephan von Haehling, Ryosuke Sato, Javed Butler, Stefan D Anker
Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure. European journal of heart failure 25 (2) (2023)
Gianluigi Savarese, Joann Lindenfeld, Davide Stolfo, Kirkwood Adams, Tariq Ahmad, Nihar R Desai, Enrico Ammirati, Stephen S Gottlieb, Mitchell A Psotka, Giuseppe M C Rosano, Larry A Allen
Use of patient-reported outcomes in heart failure: from clinical trials to routine practice. European journal of heart failure 25 (2) (2023)
Alberto Aimo, Antoni Bayes-Genis
Biomarkers of inflammation in heart failure: from risk prediction to possible treatment targets. European journal of heart failure 25 (2) (2023)
Hoong Sern Lim, Ivan H W Yim
De novo aortic regurgitation related to left ventricular assist device therapy: the difficult questions in need of new perspectives. European journal of heart failure 25 (2) (2023)
Iris E Beldhuis, Adriaan A Voors, Jasper Tromp
Rapid uptitration: what's the evidence? European journal of heart failure 25 (2) (2023)

volume 25, number 3, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
March 2023 at a glance: pathophysiology, medical therapy and devices. European journal of heart failure 25 (3) (2023)

volume 25, number 4, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
April 2023 at a glance: focus on diagnosis and comorbidities. European journal of heart failure 25 (4) (2023)
Daniela Tomasoni, Marianna Adamo, Marco Metra
April 2023 at a glance: focus on diagnosis and comorbidities. European journal of heart failure 25 (4) (2023)

volume 25, number 5, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
May 2023 at a glance: focus on pathophysiology, comorbidities and devices. European journal of heart failure 25 (5) (2023)

volume 25, number 6, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
June 2023 at a glance: focus on worsening heart failure, heart failure with preserved ejection fraction and valvular heart disease. European journal of heart failure 25 (6) (2023)

volume 25, number 7, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
July 2023 at a glance: heart failure with preserved ejection fraction and comorbidities. European journal of heart failure 25 (7) (2023)

volume 25, number 8, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
August 2023 at a glance: Focus on epidemiology and medical therapy. European journal of heart failure 25 (8) (2023)

volume 25, number 9, 2023

Daniela Tomasoni, Marianna Adamo, Marco Metra
September 2023 at a glance: focus on acute heart failure and health status. European journal of heart failure 25 (9) (2023)